Table 1.
Study or sub-group | 30 days | 90 days | Odds ratio, M–H, fixed (95% CI) | ||
---|---|---|---|---|---|
|
|
||||
Eventsa | Total, N | Eventsa | Total, N | ||
Lipid-lowering medication | |||||
Batal et al (2007)28 | 303 | 833 | 1307 | 2553 | 0.55 (0.46 to 0.64) |
Hermes et al (2010)25 | 20 820 | 31 982 | 5414 | 7219 | 0.62 (0.59 to 0.66) |
| |||||
Antihypertensive medication | |||||
Hermes et al (2010)25 | 41 064 | 53 192 | 7928 | 9405 | 0.63 (0.59 to 0.67) |
| |||||
Diabetic medication | |||||
Hermes et al (2010)25 | 6094 | 8844 | 1221 | 1578 | 0.65 (0.57 to 0.74) |
| |||||
Antidepressant medication | |||||
Pfeiffer et al (2012)30 | 123 993 | 296 634 | 67 077 | 87 000 | 0.21 (0.21 to 0.22) |
Events = refers to the number of patients with ≥80% medication adherence. M–H = Mantel–Haenszel. N = the total number of participants evaluated in each arm of the study.